Insider filing · ARWR
Michael S Perry
Director
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Michael S Perry sold $992K of Arrowhead Pharmaceuticals (ARWR)
Executed Dec 5 2025, disclosed Dec 9 2025, 4 days later.
Value, as filed
$992K
16,250 sh × $61.03
Executed
Dec 5 2025
the trade date, as filed
Disclosed
Dec 9 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MPMichael S Perry (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $1.0M of ARWR (11,600 sh × $87.30, as filed), executed Aug 18.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael S Perry in ARWR
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
$1.0M11,600 sh × $87.30
Exec Aug 18
Filed Aug 20 · 5:22 PM ET